SCHEMBL13675484

SCHEMBL13675484

Nc1nc(-c2cccc(C=O)c2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.59
RAB9A P51151 8/20 0.59
MAPT P10636 6/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
KDM4E B2RXH2 4/20 0.59
HPGD P15428 3/20 0.59
HK1 P19367 1/20 0.59
HKDC1 Q2TB90 1/20 0.59
FBP1 P09467 1/20 0.56
NPC1 O15118 6/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
NFKB1 P19838 2/20 0.53
NFKB2 Q00653 2/20 0.53
RELA Q04206 2/20 0.53
LMNA P02545 2/20 0.53
CYP3A4 P08684 1/20 0.53
AR P10275 1/20 0.53
GFER P55789 1/20 0.53
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4538229 0.83 RECQL (0.60) ALDH1A1RAB9AMAPTKDM4EHPGD
SCHEMBL10657865 0.78 KDM4E (0.55) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL4636395 0.78 TSHR (0.72) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL1399840 0.76 ALDH1A1 (0.76) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL12171395 0.76 KDM4E (0.60) ALDH1A1RAB9AKMT2AKDM4ENPC1
SCHEMBL3174985 0.75 PARP1 (0.45) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL1804064 0.75 MAPT (0.65) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL1091753 0.75 ALDH1A1 (1.00) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL21586267 0.75 HSD17B1 (0.70) ALDH1A1RAB9AMAPTMEN1KMT2A
SCHEMBL12592119 0.75 ALDH1A1 (0.65) ALDH1A1RAB9AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605264-B2 Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-20 US disclosed
US-7544808-B2 Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2009-06-09 US disclosed